Pancreatic regeneration in response to tissue injury is a complex process. Recent progress in the understanding of this process has underscored the need for cellular plasticity as a prerequisite in the course of regeneration. A number of different pancreatic cell types have been proposed as progenitors, stem cells or differentiated cells with a high degree of plasticity. Moreover, in the setting of an oncogenic mutation, similar mechanisms appear to drive pancreatic tumorigenesis. Here, we aim to summarize the recent advances in our understanding of cellular plasticity in the setting of regeneration and tumorigenesis.
Introduction
The pancreas possesses a remarkable capacity to respond to injurious insults and regenerates after cessation of tissue injury. This ability has generated considerable interest in the underlying mechanisms for this regenerative response. In general, two possibilities for tissue regeneration in the adult exist: (1) the presence of bona fide or facultative stem cells or (2) differentiated cells with the ability to de-or transdifferentiate and then proliferate in response to injury [1] [2] [3] . The scientific interest in adult pancreatic stem cells has largely been fueled by the interest in developing regenerative therapies for diabetic patients. Potential strategies for regenerating pancreatic islet cells have been extensively reviewed previously and are beyond the scope of this review [4] . Only in the last decade, the cellular mechanisms for regeneration within the pancreatic exocrine compartment have gained increasing interest. Despite major scientific efforts, true stem cells in the adult pancreas have not been found and their existence appears unlikely. Nevertheless, an understanding of the mechanisms underlying regeneration of the pancreas might provide insights into the process of malignant transformation of the pancreas. As pancreatic ductal adenocarcinoma is a major health burden, a deeper understanding of its core biology is imperative for future diagnostic and therapeutic measures. Here, we will outline the recent progress in the understanding of cellular plasticity in the process of exocrine pancreatic regeneration and tumorigenesis.
Cellular Plasticity in the Pancreas
Under resting conditions, there is a steady but slow turnover of pancreatic endocrine and exocrine cells. After injury, cell division rates increase markedly and the tissue mass is restored to a certain extent but not completely, given the limited regenerative capacity of the pancreas compared to say, the liver. The drivers of this cellular response in the pancreas have been a point of considerable debate, with some investigators favoring the existence of dedicated pancreatic stem cells, while others proposing that differentiated cells drive pancreatic regeneration through an intermediate stage involving dedifferentiation [1, 3, 5, 6] .
In the search for potential pancreatic stem cells, investigators have turned to clonogenic or sphere forming assays [7] . These experiments yielded the finding that the most efficient clonogenic cells seem to reside within a subset of ductal cells and/or in centroacinar cells [8, 9] . However, in contrast to studies in other organ systems, there are insufficient experimental data supporting the concept that these clonogenic cells serve as pancreatic stem cells in vivo. While ductal cells acquire some features of embryonic progenitor cells in response to pancreatic injury [10] , lineage-tracing experiments using a variety of ductal Cre-markers did not show convincing evidence of differentiation of ductal cells into other pancreatic lineages after pancreatic injury [1] . However, these findings do not rule out the possible existence of a subset of ductal cells with a higher degree of plasticity. In fact, recent findings from our labs have provided evidence for a rare subset of Prrx1+ ductal cells with a remarkable degree of sphere forming ability and features of progenitor cells [11] . In fact, Prrx1 ductal cells expanded markedly after cerulein-induced pancreatitis, consistent with a role in pancreatic regeneration after injury [11] . Of note, Prrx1+ serve as stem cells in bone and cartilage formation [12] .
Acinar to Ductal Metaplasia
In response to pancreatic tissue damage, complex ductal structures arise. Because of their resemblance to the ductal epithelium, investigators thought initially that these structures developed from pancreatic ducts. However, seminal lineage tracing studies revealed that differentiated acinar cells are the predominant source of these ductal structures and the molecular framework of acinar-to-ductal metaplasia (ADM) was subsequently uncovered [13] [14] [15] [16] [17] . In response to injury, acinar cells reactivate an embryonic program that involves the re-expression of PDX1, Sox9 and Hes1, and the emergence of ductal markers such as CK19 [18] [19] [20] [21] . The process of ADM is reversible, and after cessation of injury, regeneration of acinar cells appears to be driven from the acinar compartment.
Since early studies applied rather broad Cre-drivers to study the process of acinar regeneration, it remained unclear if there are subsets of acinar cells that possess more plasticity than others. Bmi1 is a marker of reserve stem cells in the intestine [22] . Using Bmi1-CreERT mice, Capecchi and colleagues defined a subset of long-lived acinar cells in the adult pancreas. They proposed a role for these cells in pancreatic regeneration, as they found an expansion of this lineage after pancreatic injury. However, since labeling of the cells was induced only after injurious insult to the pancreas, it remained unclear if the regeneration occurred from existing Bmi1+ cells, or from newly generated Bmi1+ cells secondary to upregulation of the Bmi1 transcript [23] . Dclk1 has been proposed as a marker of quiescent stem cells in the intestine and the pancreas [24] [25] [26] . Using Dclk1 BAC-CreERT mice, we were able to show that Dclk1 labels rare and long-lived cells in the adult pancreas [27] . While quiescent under homeostatic conditions, these cells became activated following diverse forms of pancreatic injury and contribute to organ regeneration. Loss of Dclk1+ cells (through diphtheria toxin-mediated cell ablation) prevented pancreatic repair and caused significant mortality after cerulein-induced pancreatitis. Finally, we were able to demonstrate that Dclk1+ cells had a proliferative advantage over the Dclk1-compartment, arguing against the hypothesis that all acinar cells are equal and that a stochastic model underlies the regenerative processes in the pancreas [27] .
Centroacinar cells have been proposed as yet another source of pancreatic stem cells due to their location at the tip of the ductal tree, and their transcriptional profile [2, 6, 9, 28] . While these cells express embryonic markers and form pancreatic organoids with higher frequency than other cell types, subsequent lineage tracing studies did not reveal a major contribution of centroacinar cells to the regenerating pancreas [29, 30] .
In summary, cellular plasticity may be an important driver of exocrine pancreatic regeneration. In particular, the existence of specialized subsets of acinar and ductal cells with a higher degree of plasticity has emerged in recent studies. Consequently, it is tempting to speculate that these cells are potential candidates for facultative progenitor cells involved in pancreatic repair after injury.
Cellular Plasticity in Pancreatic Tumorigenesis
As outlined above, cellular plasticity within the exocrine compartment plays an important role in pancreatic regeneration. Furthermore, cellular plasticity seems to be an underlying mechanism for malignant progression [31] . Pancreatic ductal adenocarcinoma (PDAC) was originally thought to arise from cells of the ductal epithelium because of its histological appearance [32] . However, in genetically engineered mouse models of PDAC, a variety of different pancreatic cell types possess the ability to give rise to precursors of pancreatic cancer [33, 34] . Acinar-to-ductal metaplasia, similar to that seen in response to pancreatic injury, can be observed when an oncogenic Kras mutation is targeted to the acinar compartment [35] . In contrast to the transient nature of injury-induced ADM, Kras-induced ADM persists and is also termed acinar-to-ductal reprogramming (ADR) [19, 36] . Importantly, expression of mutant Kras in adult acinar cells not only causes ADM/ADR but is sufficient to induce formation of pancreatic intraepithelial neoplasia (PanIN), a precursor of pancreatic cancer [35] .
PanINs resemble ductal structures, and like PDAC were originally thought to be derived from the ductal epithelium. Lineage tracing studies, however established firmly the acinar compartment as the predominant source of murine PanINs [35] . Targeting mutant Kras to the adult acinar compartment was shown to be sufficient to induce PanIN formation. However, progression to PDAC is infrequently observed in these models, particularly when Kras is targeted to adult pancreatic acinar cells. By contrast, Kras mutant acinar cells readily give rise to PDAC when subjected to experimental pancreatitis [37, 38] . Given the fact that pancreatitis reactivates an embryonic program in acinar cells and increases their plasticity, it is not surprising that the combination of an oncogenic mutation and an inflammatory insult converts pancreatic acinar cells into potent cancer initiating cells. In fact, Sander and co-workers were able to show that pancreatic acinar cells are >100 times more efficient in their ability to give rise to murine PanINs when compared to duct cells [39] . While these studies clearly pointed towards an important role of acinar cells as an origin of pancreatic neoplasia, they failed to answer the question if indeed all acinar cells were alike or if some acinar cells existed that were more prone to give rise to PanINs. Bailey and co-workers were the first to investigate the role of Dclk1+ cells in murine PanINs and pancreatic cancer cell lines. They found that Dclk1 labeled a morphologically and functionally distinct subset of cells within PanINs and pancreatic cancer cell lines. Functionally, these cells displayed a high degree of sphere forming capacity and stemness. Furthermore, they were found to be potent cancer initiating cells in transplantation experiments [40] . Using our Dclk1 BAC-CreERT transgenic mice, we investigated the role of Dclk1+ cells in the initiation of pancreatic cancer. Targeting mutant Kras expression specifically to adult pancreatic Dclk1+ cells had no effect on their quiescence and longevity. Similar to the behavior of other acinar cells, the combination of an oncogenic mutation in Dckl1+ cells with an injurious insult (cerulein-induced pancreatitis) led to the emergence of PanINs from Dclk1+ lineage traced cells. Given their exceptional role in pancreatic regeneration, we investigated if these cells were more efficient to give rise to PanINs than the bulk of the acinar compartment. The basic helix-loop-helix transcription factor, Mist1, labels the majority of adult acinar cells. Accordingly, cerulein-induced pancreatic leads to widespread PanIN development in mice with mutant Kras targeted to the Mist1 compartment. To estimate the degree of transformation of pancreatic Dclk1+ cells we compared the efficiency of Dclk1+ and Mist1+ lineage traced cells to give rise to PanINs after pancreatitis. We found that Dclk1+ cells were up to 12x more efficient in the induction of PanINs when compared to the Mist1+ acinar cells alone. These findings are consistent with the plasticity of Dclk1+ cells observed in pancreatic sphere cultures and pancreatic regeneration [27] .
While there is compelling evidence that acinar cells serve as the major source of murine PanINs, a number of observations have also pointed to ductal cells as an origin for PanIN lesions. Targeted expression of mutant Kras to CK19+ ductal cells was sufficient to induce low frequency PanIN development [41] . Recently, Leach and co-workers were able to show that pancreatic cancer can also be derived from the ductal epithelium using Hnf1bCreERT mice, where the duct specific transcription factor Hnf1b drives CreERT expression. In their experiments, mutant Kras targeted to the ductal epithelium was not sufficient to initiate pancreatic tumorigenesis. However, combined expression of mutant Kras and two mutant p53 alleles (R172H) led to rapid development of PDAC from Hnf1b+ lineage traced cells. Importantly, no other stimulus such as pancreatic injury was needed to induce malignant transformation. Of note, PanIN lesions were only infrequently observed when PDAC was driven from Kras mt/wt /p53 mt/mt ductal cells [42] . Thus, in contrast to the acinar model where pancreatitis provides a second hit to induce pancreatic cancer, in the ductal model, the mutation (and loss of heterozygosity) of a tumor suppressor gene (p53) suffices as the "second hit" to drive progression to mPDAC [43] . Taken together, these findings show that both ductal and acinar cells harbor the ability to initiate pancreatic cancer in mice.
Interestingly, pancreatic organoids, a long-term three-dimensional culture system of pancreatic epithelial cells, appear to be derived from pancreatic ductal epithelium [44] . While primary culture of acinar cells is possible as well and has been used to study acinar to ductal metaplasia [13, 45] , long-term primary cultures of acinar cells have not been established to date. Even if one takes into account, that acinar cells represent the vast majority of pancreatic epithelial cells, experiments with forced expression of mutant Kras suggest that a subset of acinar cells have a much higher degree of plasticity. This higher degree of plasticity may translate into a higher degree of susceptibility to the deleterious effects of mutant Kras and/or injury. While more resistant to Kras mutation and injury, ductal cells still retain the ability to give rise to pancreatic cancer under the appropriate conditions [42] . Our experimental data also suggest that not all acinar and ductal cells are alike. Morphology alone is insufficient to discriminate between subsets within a cellular compartment and evidence points to considerable heterogeneity within pancreatic lineages that remains to be explored. Considering the remarkable heterogeneity of pancreatic ductal adenocarcinoma -in terms of genetic alterations, histologic subtype and response to treatment -the concept of a complex, hierarchically organized pancreatic epithelium with variable susceptibility towards oncogenic insults seems plausible.
Mechanisms of Cellular Plasticity
Above we have aimed to outline, that cellular plasticity is an important mechanism in pancreatic regeneration and cancer development. The loss of cellular identity is orchestrated on a genetic and epigenetic level. Mechanistically, Sox9 seems to play a pivotal role in the reprogramming of acinar cells towards dedifferentiation and neoplasia. Sander and co-workers were able to show that loss of the Sox9 protein prevented conversion of acinar cells into PanINs; however Sox9 is not absolutely necessary for acinar to ductal metaplasia [39] . In contrast, forced overexpression of Sox9 in the setting of mutant Kras significantly enhanced pancreatic tumorigenesis through downregulation of acinar markers such as Mist1 [39] . Mist1 is a transcription factor critically involved in acinar cell identity. Mist1 expression is regulated by the transcription factor Gata6 and loss of Gata6 causes degeneration of the acinar compartment [46] . More importantly, Gata6 controls multiple differentiation programs in the adult pancreas and counteracts Kras-driven tumorigenesis [47] . Furthermore, we were able to show that the transcription factor Prrx1b binds to the Sox9 promoter positively regulating Sox9 expression and thereby promoting cellular plasticity. Importantly, Dclk1+ cells express high levels of Sox9 under resting conditions (unpublished observations), offering a potential explanation for their high degree of plasticity and transformability. Insight into the relevance of Dclk1 expression was provided by in silico and in vitro studies from our group, which suggest a direct and functionally important interaction between Dclk1 and Kras [27, [48] [49] [50] .
The Notch pathway is critically involved in cell fate decisions and regulates pancreatic development [51, 52] . In the adult, expression of Notch pathway components is restricted to centroacinar and terminal duct cells [29] . In response to pancreatic injury, Notch signaling is reactivated and critical for pancreatic regeneration [53] . During tissue repair Notch and Wnt/beta-catenin signaling cooperate to allow for acinar cell regeneration [53] . Furthermore, ongoing beta-catenin signaling is sufficient to block Kras-mediated acinar transformation underscoring [19] the importance of tightly regulated cellular identity in response to injurious stimuli.
Additionally, cellular plasticity is regulated on an epigenetic level. In zebrafish, loss of the pivotal DNA methyltransferase 1 (Dnmt1) leads to loss of the pancreas 84 hours post fertilization. While duct and endocrine cells develop normally, the acinar compartment undergoes complete apoptosis. Interestingly, loss of Dnmt1 leads to enhanced regeneration of pancreatic beta cells after targeted ablation. These early studies underscored the complex roles of epigenetic regulation in development and regeneration [54] . In injury, the epigenetic regulator Bmi1, a member of the polycomb repressor complex 1 (Prc1), is upregulated in acinar cells and coordinates regeneration in the exocrine compartment. Moreover, loss of Bmi1 greatly impairs exocrine regeneration after pancreatic injury. This is in part due to upregulation of Cdkn2a and p53-regulated proapoptotic genes [55] . Ezh2 is polycomb group protein and part of the polycomb repressor complex 2 (Prc2). Following pancreatic injury, Ezh2 mediates pancreatic regeneration by suppression of p16
Ink4a . Suppression of p16 Ink4a leads to enhanced proliferation of progenitor cells driving tissue repair. Consequently, loss of Ezh2 causes failure of pancreatic regeneration and accelerates pancreatic tumorigenesis. The complex interplay of genetic and epigenetic mechanisms mediating pancreatic plasticity and repair have recently been excellently elsewhere [31, 56] . Finally, the microenvironment plays a pivotal role in pancreatic regeneration and tumorigenesis by influencing the epithelial compartment [57] [58] [59] . In response to an injurious stimulus, acinar cells release proinflammatory factors such as Interleukin 6 (IL-6), tumor necrosis factor (TNF) and transforming growth factor-beta (TGF-beta), which in turn activate the immune system but also otherwise quiescent pancreatic stellate cells (PSC) [60] . Activated stellate cells secrete a variety of factors such as insulin-like growth factor, epidermal growth factor, hepatocyte growth factor, Nodal/Activin and platelet derived growth factor. These mediators in turn lead to increased aggressiveness of surrounding cancer cells [61] [62] [63] [64] [65] . The importance of this crosstalk between PSC and pancreatic cancer cells is demonstrated by the fact, that restoration of PSC quiescence profoundly affects cancer cells in proximity [66] . Furthermore, we were able to show that an epithelial-stromal crosstalk mediated by the transcription factor ETV1 regulates stromal expansion, epithelial to mesenchymal transition and metastatic spread underscoring the importance of the stromal compartment in regulating epithelial plasticity [67] . Immunosurveillance plays as major role to eliminate mutant cells before their expansion [68] . However, ongoing activation of the immune system is an important driver of early pancreatic tumorigenesis, in part through the NFATc1-STAT3 transcription complex [69] . Furthermore, mutant Kras causes expression of GM-CSF which in turn leads to recruitment of immunosuppressive myeloid and exclusion of cytotoxic T-cells [70, 71] .
Conclusions and Outlook
It is widely acknowledged that the most efficient cellular origin of PDAC precursors lies within the acinar epithelium. Only recently, it was proposed that specific subsets of acinar cells could exist that drive pancreatic regeneration (and tumorigenesis) [23] . Indeed, we were able to show that Dclk1 labels such a progenitor population involved in repair and cancer initiation [27] . Future studies are needed to establish if the "plastic pancreas" [5] contains more than just one of these progenitor/stem cell populations or if multiple different pools of cell types with different properties coexist in the pancreas. Of note, coexistence of different stem cell pools has been demonstrated in other organs such as the skin and the intestine [72, 73] . Additionally work from our groups has clearly demonstrated that a distinct subset of Prrx1+ ductal cells exists and that these are functionally different from the bulk of the ductal epithelium [11] . It is tempting to speculate that cancers arising in the setting of mutant Kras/p53 targeted to the duct compartment (see above) originate from this specific population.
At this point it is important to acknowledge that all of the evidence for potential origins of pancreatic cancer that is presented here is based on genetically engineered mouse models in which forced expression of oncogenes to different compartments is the common approach to answer one of the fundamental questions in pancreatic cancer research. While genetically engineered mouse models closely resemble the histology and biology of human pancreatic adenocarcinoma we do not know if the underlying mechanisms of sporadic human pancreatic cancer mirror those in mice in which the whole pancreatic anlage or the majority of a given compartment are collectively mutated to induce pancreatic tumorigenesis. A major advance in the field would be the generation of spontaneous models that do not rely on broad Cre-drivers to achieve malignant transformation. Interesting new in vivo model systems are on the rise that combine genomic engineering and at the same time recapitulate the stochastic nature of the disease [74] . Given the fact that some forms of chronic pancreatitis pose an increased risk for the development of pancreatic cancer in humans we can only speculate that the same mechanisms driving malignancy in mice also dominate the process in humans. Further studies and novel technologies such as organoid cultures and humanized animal models will be instrumental in translating these fundamental questions from mice into humans and might then help to design future preventive and therapeutic approaches for pancreatic cancer.
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